Healthcare

President Trump approval rating holds steady near 40%

Ipsos Healthcare has announced the expansion of its syndicated Pan-Cancer Testing Monitor (PCTM) to the Australian market. The PCTM, which has been running in the US since 2016, measures and tracks the usage of pan-cancer tests, which are designed to test for a wide range of cancer types to help doctors make more informed treatment decisions.

President Trump approval rating holds steady near 40%.

New global poll finds three concerns top the world’s worry list: financial/political corruption (35%), unemployment (34%) and poverty/social inequality (34%).

Ipsos Healthcare, the global healthcare business of Ipsos, has announced the launch of its syndicated Multiple Sclerosis (MS) Patient Community Panel. This latest offer is part of the Ipsos Healthcare Global Patient Centre of Excellence, launched in 2018.

Ipsos is delighted to be exhibiting at the healthcare industry’s biggest insights and analytics conference.

President Trump’s approval rating is divided by party lines, with 80% of Republicans, 36% of Independents and just 10% of Democrats approving of Trump’s performance.

President Trump's approval rating holds steady at 40%, and Attorney General Jeff Sessions continues to narrowly lead (17%) as the next executive branch staff member to be fired or resigned in the Ipsos Wh'Exit poll.

President Trump's approval rating is steady at 39%, healthcare remains the most important problem for Americans.